Raiffeisen Bank International AG
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2044885
VIENNA, C4
Position in VRTX
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$45,294,784
-$5,773,953 QoQ
Shares Held
101,435
-10.0% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 98.02829398136737.ToString("F0")%
Shared 0.ToString("F0")%
None 1.971706018632622.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2026CallValue
$385,364
CallShares
863
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Raiffeisen Bank International AG holds $97,826,369 across 28 Biotechnology names. VRTX ranks #1 (46.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
101,435 | $45,294,784 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,203 | $17,927,565 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,413 | $3,445,349 | |
| 4 | BNTX |
BioNTech SE
|
35,000 | $3,110,800 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
36,000 | $2,703,240 | |
| 6 | LEGN |
Legend Biotech Corp
|
140,000 | $2,532,600 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
26,000 | $2,528,500 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
190,000 | $1,890,500 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $385,364 | 863 | Call | Sole | 2026-04-24 | |
| 2026-03-31 | $45,294,784 | 101,435 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $51,068,737 | 112,645 | Shares | Sole | 2026-02-12 | |
| 2025-12-31 | $391,249 | 863 | Call | Sole | 2026-02-12 | |
| 2025-09-30 | $337,985 | 863 | Call | Sole | 2025-11-10 | |
| 2025-09-30 | $44,095,139 | 112,591 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $50,720,299 | 113,927 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $63,806,674 | 131,609 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $53,920,724 | 133,898 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||